This week in Drug Discovery (13 – 17 October)
News round-up for 13 – 17 October by Bruno Quinney, Content Team at DDW.
This week’s top story comes from new research showing drug therapies could prevent hereditary diseases. Elsewhere, there have been major developments in cancer research and gene therapy could help combat hearing loss.
The top stories:
Drug therapies could prevent hereditary diseases, study finds
According to a new study, researchers have pinpointed a cellular mechanism involved in the inheritance of genetic mutations. The findings could help develop treatments to reduce the risk of babies being born with serious, incurable mitochondrial diseases.
Nanoparticle-based vaccine could prevent cancer tumours, study shows
A nanoparticle-based vaccine developed by the University of Massachussets Amherst could effectively prevent melanoma, pancreatic and triple-negative breast cancer, the university reveals.
Gene therapy brings ‘new era’ in treatment of hearing loss
New gene therapy trial results have shown dramatic and sustained improvements in hearing and speech perception in children with profound genetic hearing loss.
Read more…
Major study into prostate cancer offers hope for new treatments
A major international study revealed that two enzymes play a crucial role in helping prostate cancer cells grow, survive and resist treatment. When they are blocked, the AR becomes unstable and breaks down, leading to cancer cell death and tumour shrinkage in both lab-grown cells and animal models.
DDW Symposium: Full programme announced
Registration is now open for this free event, which will feature six in-depth presentations from industry experts, a panel discussion examining new processes and technology and an opportunity for networking.